Pages that link to "Q1519099"

The following pages link to polio vaccine (Q1519099):

Displaying 50 items.

• World Health Organization Model List of Essential Medicines (Q37155) ‎ (← links)
• Albert Sabin (Q164790) ‎ (← links)
• Sabin vaccine (Q3023374) ‎ (← links)
• Bharat Immunologicals and Biologicals Corporation (Q4901119) ‎ (← links)
• (Q17937285) ‎ (← links)
• (Q19717471) (redirect page) ‎ (← links)
• Epidemics to eradication: the modern history of poliomyelitis (Q21245132) ‎ (← links)
• Poliomyelitis Prevention: Recommendations for Use of Inactivated Poliovirus Vaccine and Live Oral Poliovirus Vaccine (Q22305954) ‎ (← links)
• Intradermal fractional dose vs intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis (Q24187419) ‎ (← links)
• Oral polio vaccine plus inactivated polio vaccine versus oral polio vaccine alone for reducing polio in children under two years of age (Q24202270) ‎ (← links)
• The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis (Q24617876) ‎ (← links)
• Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study (Q24648845) ‎ (← links)
• Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine (Q24658295) ‎ (← links)
• Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children (Q24674340) ‎ (← links)
• THE FEEDING OF ORAL POLIOVIRUS VACCINE TO A CLOSED COMMUNITY EXCRETING FAECAL VIRUSES (Q24681518) ‎ (← links)
• Polio eradication. Efficacy of inactivated poliovirus vaccine in India (Q28246469) ‎ (← links)
• Caution needed in using oral polio vaccine beyond the cold chain: vaccine vial monitors may be unreliable at high temperatures (Q28727902) ‎ (← links)
• Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP). (Q30233152) ‎ (← links)
• The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants (Q30276847) ‎ (← links)
• The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems (Q30300580) ‎ (← links)
• Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine. (Q30341144) ‎ (← links)
• Origin of AIDS: contaminated polio vaccine theory refuted. (Q30341339) ‎ (← links)
• Mitochondrial DNA and retroviral RNA analyses of archival oral polio vaccine (OPV CHAT) materials: evidence of macaque nuclear sequences confirms substrate identity. (Q30350165) ‎ (← links)
• Oral polio vaccine response in breast fed infants with malnutrition and diarrhea (Q30357774) ‎ (← links)
• Polio vaccines and the origin of AIDS. (Q30419917) ‎ (← links)
• Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication (Q30690384) ‎ (← links)
• POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA. (Q30862476) ‎ (← links)
• Is there an association between SV40 contaminated polio vaccine and lymphoproliferative disorders? An age-period-cohort analysis on Norwegian data from 1953 to 1997. (Q31018509) ‎ (← links)
• Oral polio vaccine and intussusception: a data linkage study using records for vaccination and hospitalization. (Q31032060) ‎ (← links)
• Analysis of a library of macaque nuclear mitochondrial sequences confirms macaque origin of divergent sequences from old oral polio vaccine samples (Q31062882) ‎ (← links)
• Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data. (Q31134681) ‎ (← links)
• Sex-differential effect on infant mortality of oral polio vaccine administered with BCG at birth in Guinea-Bissau. A natural experiment (Q33396233) ‎ (← links)
• Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV) (Q33408703) ‎ (← links)
• Immune Thrombocytopenia Following Diphtheria Pertussis- Tetanus and Oral Polio Vaccine (Q33436219) ‎ (← links)
• Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93. (Q33463252) ‎ (← links)
• Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccination (Q33490831) ‎ (← links)
• The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial (Q33553771) ‎ (← links)
• Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model (Q33568783) ‎ (← links)
• Political refutation of a scientific theory: the case of polio vaccines and the origin of AIDS. (Q33582323) ‎ (← links)
• Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment (Q33587406) ‎ (← links)
• Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks (Q33596097) ‎ (← links)
• Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan (Q33758571) ‎ (← links)
• Experimental oral polio vaccines and acquired immune deficiency syndrome (Q33772277) ‎ (← links)
• Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative (Q33777224) ‎ (← links)
• Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America (Q33777684) ‎ (← links)
• Immunogenicity study to investigate the interchangeability among three different types of polio vaccine: A cohort study in Japan (Q33783414) ‎ (← links)
• "A calculated risk": the Salk polio vaccine field trials of 1954 (Q33792400) ‎ (← links)
• Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors (Q33835258) ‎ (← links)
• Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants (Q33848690) ‎ (← links)
• Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation (Q33873406) ‎ (← links)